Prof. Caitriona O’Driscoll, coordinator of the GENEGUT project, was recently interviewed by HNN 3.0 HEALTH-NCP-NET as part of their Horizon Health Impact Success Stories series.
“Being part of, or coordinating, a Horizon Europe project, provides significant opportunities for valuable collaborations with other EU partners, which enhances the overall impact of the research project.”
In the interview, Caitriona shares how the GENEGUT consortium is working to develop a first-in-class oral RNA-based therapy for Crohn’s disease and highlights the project’s contributions to scientific innovation, patient-centred research and regulatory preparedness. She also reflects on the importance of building the right consortium, involving patient organisations and clinicians from the start and securing dedicated project management support.
Click the button below to read the full interview on the HNN 3.0 website.
What is HNN 3.0?
HNN 3.0 (Health NCP Net 3.0) is a project funded by the European Commission to support National Contact Points for Horizon Europe Cluster 1: Health. The Impact Success Stories series features Horizon Health projects with high potential for societal and scientific impact, and aims to share good practices and inspire future applicants.